Asymmetric Reporting of Harms and Benefits in Randomized Controlled Trials

被引:16
|
作者
Yeahia, Rubaya [1 ]
Gennarelli, Renee L. [2 ]
Morgan, Daniel J. [3 ]
Korenstein, Deborah [2 ,4 ]
机构
[1] New York Med Coll, Valhalla, NY 10595 USA
[2] Mem Sloan Kettering Canc Ctr, Ctr Hlth Policy & Outcomes, 1275 York Ave, New York, NY 10021 USA
[3] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA
关键词
D O I
10.1007/s11606-021-07056-1
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页码:2113 / 2115
页数:3
相关论文
共 50 条
  • [21] The reporting of randomized controlled trials in prosthodontics
    Jokstad, A
    Esposito, M
    Coulthard, P
    Worthington, HV
    INTERNATIONAL JOURNAL OF PROSTHODONTICS, 2002, 15 (03) : 230 - 242
  • [22] The quality of reporting of randomized controlled trials
    McGowan, David R.
    Norris, Joseph M.
    Bennett, Grace L.
    CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (08) : 1609 - 1610
  • [23] Reporting process of randomized controlled trials
    Maksymowych, WP
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 170 (09) : 1375 - 1375
  • [24] REPORTING RANDOMIZED CONTROLLED TRIALS - REPLY
    MOHER, D
    RENNIE, D
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (17): : 1342 - 1343
  • [25] Adherence reporting in randomized controlled trials
    Zhang, Ze
    Peluso, Michael J.
    Gross, Cary P.
    Viscoli, Catherine M.
    Kernan, Walter N.
    CLINICAL TRIALS, 2014, 11 (02) : 195 - 204
  • [26] CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials
    Junqueira, Daniela R.
    Zorzela, Liliane
    Golder, Susan
    Loke, Yoon
    Gagnier, Joel J.
    Julious, Steven A.
    Li, Tianjing
    Mayo-Wilson, Evan
    Pham, Ba
    Phillips, Rachel
    Santaguida, Pasqualina
    Scherer, Roberta W.
    Gotzsche, Peter C.
    Moher, David
    Ioannidis, John P. A.
    Vohra, Sunita
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2023, 158 : 149 - 165
  • [27] The reporting of harms in randomized controlled trials funded by the "Programme Hospitalier de Recherche Clinique", a French national funding
    Crepin, S.
    Favier, R.
    Merle, L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2015, 29 : 6 - 6
  • [28] A PROPOSAL FOR STRUCTURED REPORTING OF RANDOMIZED CONTROLLED TRIALS
    ANDREW, E
    ANIS, A
    CHALMERS, T
    CHO, M
    CLARKE, M
    FELSON, D
    GOTZSCHE, P
    GREENE, R
    JADAD, A
    JONAS, W
    KLASSEN, T
    KNIPSCHILD, P
    LAUPACIS, A
    MEINERT, CL
    MOHER, D
    NICHOL, G
    OXMAN, A
    PENMAN, MF
    POCOCK, S
    REISCH, J
    SACKETT, D
    SCHULZ, K
    SNIDER, J
    TUGWELL, P
    TYSON, J
    VARIN, F
    WALOP, W
    WALSH, S
    WELLS, G
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (24): : 1926 - 1931
  • [29] Reporting adverse events in randomized controlled trials
    Nuovo, Jim
    Sather, Curtis
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (03) : 349 - 351
  • [30] Bias in the analysis and reporting of randomized controlled trials
    Stewart, LA
    Parmar, MKB
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 1996, 12 (02) : 264 - 275